Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David De Bels and Sebastien Redant.
Connection Strength

6.061
  1. Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients. J Transl Int Med. 2020 12; 8(4):255-260.
    View in: PubMed
    Score: 0.921
  2. Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies. Crit Care. 2021 07 22; 25(1):259.
    View in: PubMed
    Score: 0.239
  3. Understanding the Underlying Mechanisms of Hyponatremia in Coronavirus Disease 2019 Is Critical Since Treatment Varies Based on Etiology: Let Us Not Forget Critical Illness-Related Corticosteroid Insufficiency As the Treatment Is Very Different and Often Lifesaving! Crit Care Med. 2021 07 01; 49(7):e724-e725.
    View in: PubMed
    Score: 0.238
  4. A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure! Chest. 2021 07; 160(1):e85-e86.
    View in: PubMed
    Score: 0.238
  5. Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two? Chest. 2021 07; 160(1):e88-e89.
    View in: PubMed
    Score: 0.238
  6. Severe Acute Respiratory Syndrome Coronavirus-2-Associated Acute Kidney Injury: A Narrative Review Focused Upon Pathophysiology. Crit Care Med. 2021 05 01; 49(5):e533-e540.
    View in: PubMed
    Score: 0.236
  7. Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? Intensive Care Med Exp. 2021 Mar 12; 9(1):16.
    View in: PubMed
    Score: 0.233
  8. SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy. Crit Care. 2020 10 22; 24(1):623.
    View in: PubMed
    Score: 0.227
  9. Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider. Crit Care. 2020 10 09; 24(1):603.
    View in: PubMed
    Score: 0.227
  10. TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction? Crit Care. 2020 10 06; 24(1):599.
    View in: PubMed
    Score: 0.227
  11. Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction? Crit Care. 2020 09 07; 24(1):551.
    View in: PubMed
    Score: 0.225
  12. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure. Crit Care. 2020 08 04; 24(1):482.
    View in: PubMed
    Score: 0.224
  13. Inhibiting IL-6 in COVID-19: we are not sure. Crit Care. 2020 07 27; 24(1):463.
    View in: PubMed
    Score: 0.224
  14. Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation. Crit Care. 2020 06 16; 24(1):352.
    View in: PubMed
    Score: 0.222
  15. With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes? Crit Care. 2020 05 18; 24(1):234.
    View in: PubMed
    Score: 0.221
  16. Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure. Crit Care. 2020 05 15; 24(1):226.
    View in: PubMed
    Score: 0.221
  17. Urgent need for a randomized controlled trial with only septic patients! Ann Intensive Care. 2019 Oct 21; 9(1):121.
    View in: PubMed
    Score: 0.212
  18. Elevated Lactic Acid During Ketoacidosis: Pathophysiology and Management. J Transl Int Med. 2019 Sep; 7(3):115-117.
    View in: PubMed
    Score: 0.212
  19. Acute coronary syndrome and diabetic keto acidosis: the chicken or the egg? Ann Transl Med. 2019 Aug; 7(16):397.
    View in: PubMed
    Score: 0.209
  20. Is interleukin-8 a true predictor of pediatric acute respiratory distress syndrome outcomes? Beware of potential confounders. Crit Care. 2019 06 27; 23(1):233.
    View in: PubMed
    Score: 0.207
  21. Cardiogenic Shock after Nifedipine Administration in a Pregnant Patient: A Case Report and Review of the Literature. J Transl Int Med. 2018 09; 6(3):152-156.
    View in: PubMed
    Score: 0.197
  22. Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue? Crit Care. 2019 09 05; 23(1):304.
    View in: PubMed
    Score: 0.053
  23. Endotoxin removal by polymyxin B: is it a question of dose or duration or both? Crit Care. 2019 09 04; 23(1):297.
    View in: PubMed
    Score: 0.053
  24. Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said! J Transl Int Med. 2019 09; 7(3):121-122.
    View in: PubMed
    Score: 0.052
  25. Adsorption and caspofungin dosing during continuous renal replacement therapy. Crit Care. 2019 07 02; 23(1):240.
    View in: PubMed
    Score: 0.052
  26. Improve short-term survival in postcardiotomy cardiogenic shock by simultaneous use of intra-aortic balloon pumping with veno-arterial extracorporeal membrane oxygenation: Beware of confounders! Ann Intensive Care. 2019 Jul 01; 9(1):77.
    View in: PubMed
    Score: 0.052
  27. Attainment of therapeutic vancomycin level within the first 24 h. Crit Care. 2019 06 21; 23(1):228.
    View in: PubMed
    Score: 0.052
  28. Heparin-binding protein in sepsis: player! predictor! positioning? Ann Intensive Care. 2019 Jun 20; 9(1):71.
    View in: PubMed
    Score: 0.052
  29. Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration? Ann Intensive Care. 2019 Mar 08; 9(1):35.
    View in: PubMed
    Score: 0.051
  30. Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? Crit Care. 2018 11 01; 22(1):289.
    View in: PubMed
    Score: 0.050
  31. Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia? Crit Care. 2018 11 01; 22(1):290.
    View in: PubMed
    Score: 0.050
  32. Citrate: How to Get Started and What, When, and How to Monitor? J Transl Int Med. 2018 09; 6(3):115-127.
    View in: PubMed
    Score: 0.049
  33. Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an "endotoxin severity score" needed? Crit Care. 2018 08 17; 22(1):205.
    View in: PubMed
    Score: 0.049
  34. Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose. Crit Care. 2018 08 16; 22(1):207.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.